Maternal & Child Health Research Institute (MCHRI)
Showing 901-996 of 996 Results
-
Robert Tibshirani
Professor of Biomedical Data Science and of Statistics
Current Research and Scholarly InterestsMy research is in applied statistics and biostatistics. I specialize in computer-intensive methods for regression and classification, bootstrap, cross-validation and statistical inference, and signal and image analysis for medical diagnosis.
-
Seda Tierney
Professor of Pediatrics (Cardiology)
Current Research and Scholarly InterestsAssessment of vascular health in children by non-invasive modalities
Exercise interventions in children with congenital and acquired heart disease
Use of telehealth to deliver interventions to children with congenital and acquired heart disease
Parentally-acquired echocardiograms
Quality Improvement in Pediatric Echocardiography
Echocardiography and outcomes in congenital heart disease -
Alice Ting
Professor of Genetics, of Biology and, by courtesy, of Chemistry
On Leave from 09/22/2025 To 06/10/2026Current Research and Scholarly InterestsWe develop chemogenetic and optogenetic technologies for probing and manipulating protein networks, cellular RNA, and the function of mitochondria and the mammalian brain. Our technologies draw from protein engineering, directed evolution, computational design, chemical biology, organic synthesis, microscopy, and genomics.
-
Jyothi Tirumalasetty, MD, FAAAAI
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsReducing healthcare-related carbon emissions with a focus on inhalers.
Health disparities in food allergy.
Climate change and asthma. -
Christina (Christy) Tise, MD, PhD
Assistant Professor of Pediatrics (Genetics) and, by courtesy, of Obstetrics & Gynecology (Reproductive Endocrinology and Infertility)
BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.
Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.
Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!
Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS -
Natalie Torok
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsOur lab is focused on exploring the role of matrix remodeling in disease progression in metabolic dysfunction steatohepatitis (MASH)-related hepatocellular carcinoma and primary sclerosing cholangitis. Our goal is to uncover how biomechanical characteristics of the ECM affect mechano-sensation, and how these pathways could ultimately be targeted. We are also interested in aging and its effects on metabolic pathways in MASH and HCC.
-
Jennifer Tremmel
Susan P. and Riley P. Bechtel Medical Director and Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Tremmel studies sex differences in cardiovascular disease. Current research projects include evaluating sex differences in coronary pathophysiology, young patients presenting with myocardial infarction, the impact of stress on anginal symptoms, chronic total coronary occlusions, and vascular access site complications.
-
Jennifer Tsai
Adjunct Clinical Instructor, Pediatrics - Hematology & Oncology
BioJennifer is a researcher in clinical development of novel therapeutics for hematologic diseases. She has a special interest in rare pediatric disorders.
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Chi-Ho Ban Tsui
Adjunct Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Tsui completed his medical training at Dalhousie University in Halifax in 1995, following his Master of Science in Pharmacy in 1991. These degrees followed a Diploma in Engineering and a Bachelor of Science in both Mathematics and Pharmacy. After 16 years of practice at the University of Alberta Hospital and Stollery Children’s Hospital, Dr. Tsui was recruited to Stanford University in 2016.
Dr. Tsui is an avid and internationally recognized researcher. During his residency, Dr. Tsui developed an interest in improving the accuracy of epidural catheter placement and was issued a U.S. patent for his research. Dr. Tsui has expanded his research on ultrasound in regional anesthesia, with particular relevance to peripheral nerve block performance. Dr. Tsui is also responsible for developing the E-Catheter catheter-over-needle kit for use during peripheral nerve blocks. The primary objective of his research is to transform regional anesthesia from an “art” into a reliable and reproducible “science” by further exploring the fundamental scientific and clinical aspects of electrophysiological signal monitoring and integrating this with the latest advances in ultrasound.
Academically, Dr. Tsui received the 2005 John Bradley Young Educator Award from the Canadian Anesthesiologists' Society. This award recognizes his work as a clinical educator, researcher, and anesthesia trainee role model. While in Canada, Dr. Tsui was the only Canadian invited to write a chapter for a prestigious American anesthesia textbook - Clinical Anesthesia (Barash). Dr. Tsui wrote the first textbook on Ultrasound and Nerve Stimulation-Guided Regional Anesthesia. Dr. Tsui also co-authored the first pediatric textbook on the subject, the Pediatric Atlas of Ultrasound- and Nerve Stimulation-Guided Regional Anesthesia. Dr. Tsui co-authored and edited "Principles of Airway Management" and "Complications in Regional Anesthesia." From 2006 to 2018, Dr. Tsui served on the editorial board of the Canadian Journal of Anesthesia. Dr. Tsui is currently the editor of the Regional Anesthesia and Pain Medicine.
Dr. Tsui has received the Alberta Heritage Foundation for Medical Research (AHFMR) Clinical Scholar award and has previously received research awards and grants from the Canadian Institutes of Health Research (CIHR), Canadian Anesthesiologists’ Society, AHFMR, and University of Alberta. In 2015, the CAS Research Recognition Award, a prestigious award presented by the Canadian Anesthesiologists’ Society, was awarded to Dr. Tsui "in recognition of significant research contributions to regional anesthesia, acute pain management, and pediatric anesthesia in Canada and around the world". In 2022, the American Society of Regional Anesthesia and Pain Medicine (ASRA) awarded Dr. Tsui the Distinguished Service Award. This prestigious annual award honors individuals who have made remarkable contributions to the field of regional anesthesia and pain medicine
In 2025, in celebration of its 50th anniversary, ASRA honored Prof. Ban C.H. Tsui with the prestigious Gaston Labat Award. Presented annually since 1977 to recognize exceptional contributions to regional anesthesia, ASRA specifically chose Prof. Tsui as the 2025 recipient to mark this significant milestone.
Dr. Tsui was a full professor and is now an adjunct professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University. Recently, the Chinese University of Hong Kong, Shenzhen, recruited Dr. Tsui as an associate dean (Clinical Innovation & Translational Research), Chair, and Chief of the Department of Anesthesiology, Critical Care, and Pain Medicine. He was then shortly promoted to the position of Executive Associate Dean of the School of Medicine. Dr. Tsui is also an Honorary Full Professor at the Chinese University of Hong Kong. -
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone, MD, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford School of Medicine. A neuroscientist and psychiatrist, he leads a laboratory focused on uncovering the biological mechanisms of mental illness and developing novel therapies for mood disorders and addiction. His research centers on defining new cell types and evolutionarily conserved neural circuits involved in emotional processing, with the goal of identifying new therapeutic entry points. Using optogenetic, chemogenetic, neuroimaging, and behavioral approaches in mouse models of addiction, his lab investigates vulnerable brain circuitry underlying opioid use disorder. He also works and collaborates with the Depression Research Clinic, participating in academic and industry sponsored clinical trials investigating novel antidepressant therapies.
Clinically, Dr. Tucciarone works in Stanford’s Neuropsychiatry Clinic, where he treats patients with complex presentations at the interface of psychiatry and neurology, with particular interest in functional neurological disorders. He also sees a small cohort of psychotherapy patients in the Individual Psychotherapy Clinic and works shifts on Stanford’s inpatient psychiatry units.
Dr. Tucciarone completed his psychiatry training through Stanford’s Research Residency Track, where he conducted postdoctoral research under the supervision of Drs. Robert Malenka and Alan Schatzberg. During residency, his research examined neural circuits recruited during opioid withdrawal and explored strategies to enhance the anti-suicidal effects of ketamine through μ-opioid receptor partial agonism.
He received his bachelor’s degree in biology and philosophy from Union College, followed by three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke, where he developed MRI-reportable contrast agents to map neuronal connectivity. He then entered the Medical Scientist Training Program (MD/PhD) at Stony Brook University, completing his PhD in neuroscience under the mentorship of Dr. Josh Huang at Cold Spring Harbor Laboratory. His doctoral work used mouse genetic approaches to dissect excitatory and inhibitory cortical circuits, with a focus on chandelier interneurons in the prefrontal cortex.
In addition to his research and clinical work, Dr. Tucciarone is deeply committed to teaching and mentorship. During residency, he helped restructure neuroscience education for trainees and currently teaches introductory lectures on the neuroscience of addiction, PTSD, psychosis, and mood disorders. He leads resident group supervision in introductory psychodynamic psychotherapy and supervises undergraduates, medical students, residents, and clinical fellows in psychiatry clinics. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Affiliate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Ndidi Unaka
Clinical Professor, Pediatrics
BioDr. Unaka is the inaugural Chief Health Equity Officer (CHEO) for Stanford Medicine Children’s Health (SMCH) and a Clinical Professor in the Department of Pediatrics at Stanford University School of Medicine. Prior to her transition to SMCH in July 2024, Dr. Unaka was a faculty member in the Division of Hospital Medicine at Cincinnati Children's Hospital. In addition to her clinical role as a pediatric hospitalist, Dr. Unaka served as the Associate Program Director of the Pediatric Residency Program from 2011 – January 2022. She served as the medical director of a 48- bed inpatient unit primarily for patients admitted to the Hospital Medicine service. In this role, Dr. Unaka was involved in several equity-oriented quality improvement initiatives which included work to identify, and address hunger among caregivers of hospitalized children insured by Medicaid.
Dr. Unaka worked on institution-level community health initiatives at Cincinnati Children’s. She served as the Medical Director of Quality Improvement and Data Analytics for Cincinnati Children’s Medicaid- focused, accountable care organization (HealthVine). In this role, she developed and led initiatives designed to improve the quality and efficiency of health care delivery to HealthVine’s patient population and helped lead the change management associated with the movement toward a population-health care model that improves quality, narrows equity gaps, streamlines care, and reduces costs. She helped define appropriate health care delivery, equity, and population health measures and quality benchmarks. Additionally, Dr. Unaka was a faculty lead within Cincinnati Children's Fisher Child Health Equity Center, and she specifically focused on working with operations leaders to ensure equity was embedded within all strategic plans, goals, and metrics across all sites of care. Dr. Unaka partnered with several colleagues to lead system-wide quality improvement initiatives including work accelerated via learning networks. She was the co-lead of Cincinnati Children's Health Equity Network (HEN), an initiative borne out of the pursuit of excellent and equitable health outcomes for youth in Greater Cincinnati. The HEN supports clinical teams seeking to eliminate disparities in child health outcomes by race, ethnicity, and/or socioeconomic status via targeted interventions and best practices by addressing both medical and social factors known to confer poor health outcomes. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
PJ Utz
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
-
Tulio Valdez, MD, MSc
Professor of Otolaryngology - Head & Neck Surgery (OHNS) and, by courtesy, of Pediatrics
BioDr. Tulio A Valdez is a surgeon scientist with a subspecialty interest in Pediatric Otolaryngology. He attended medical school at Universidad Javeriana in Bogota Colombia before undertaking his residency in Otolaryngology, Head and Neck Surgery in Boston. He completed his Pediatric Otolaryngology Fellowship at Texas Children’s Hospital (2007), Houston and obtained his Master’s in Clinical and Translational Research at the University of Connecticut.
Clinically, Dr. Valdez has an interest in pediatric sleep apnea. He has a special interest in the management of sinus disease in cystic fibrosis. Dr. Valdez has co-authored one textbook and numerous book chapters and scientific manuscripts. Dr. Valdez continues his clinical research in these areas, particularly with a focus on aerodigestive disorders.
Scientifically, Dr. Valdez has developed various imaging methods to diagnose otitis media and cholesteatoma a middle ear condition that can lead to hearing loss. He was part of the Laser Biomedical Research Center at the Massachusetts Institute of Technology. His research includes novel imaging modalities to better diagnose ear infections one of the most common pediatric problems. His research has now expanded to include better intraoperative imaging modalities in pediatric patients to improve surgical outcomes without the need for radiation exposure.
Dr. Valdez believes in multi-disciplinary collaborations to tackle medical problems and has co-invented various medical devices and surgical simulation models. -
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
-
Keith Van Haren, MD
Associate Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsOur research team is working to develop new treatments for children at risk of neurodegenerative diseases. We are primarily focused on multiple sclerosis and X-linked adrenoleukodystrophy, two conditions that involve inflammatory and metabolic disruption of the myelin that insulates brain cells. A key area of interest for us is how nutrient deficiencies during childhood may contribute to the disease processes and whether nutritional interventions could play a role in prevention.
-
Krisa Van Meurs
Rosemarie Hess Professor, Emerita
Current Research and Scholarly InterestsMy research interests include persistent pulmonary hypertension of the newborn, hypoxic respiratory failure, inhaled nitric oxide therapy, ECMO, congenital diaphragmatic hernia, neonatal clinical trials, and the use of aEEG and NIRS to detect brain injury.
-
Capucine Van Rechem
Assistant Professor of Pathology (Pathology Research)
Current Research and Scholarly InterestsMy long-term interest lies in understanding the impact chromatin modifiers have on disease development and progression so that more optimal therapeutic opportunities can be achieved. My laboratory explores the direct molecular impact of chromatin-modifying enzymes during cell cycle progression, and characterizes the unappreciated and unconventional roles that these chromatin factors have on cytoplasmic function such as protein synthesis.
-
Shreyas Vasanawala, MD/PhD
William R. Brody Professor of Pediatric Radiology and Child Health
Current Research and Scholarly InterestsOur group is focused on developing new fast and quantitative MRI techniques.
-
Alexander Michael Vezeridis, MD, PhD
Assistant Professor of Radiology (Interventional Radiology)
BioAlexander Vezeridis MD, PhD is an Assistant Professor of Radiology at Stanford University School of Medicine, and a physician-scientist specializing in Interventional Radiology. His clinical expertise includes interventional oncology, biliary disease and endoscopy, venous disease, portal hypertension, urologic interventions, women’s and men’s health interventions, and general vascular/interventional radiology.
Dr. Vezeridis is an active researcher with expertise in translational techniques in engineering to make image-guided interventions safer and more effective for patients.
Dr. Vezeridis obtained his undergraduate, MD, and PhD degrees from Boston University. He completed a two year post-doctoral training at UC San Diego in ultrasound molecular imaging under the auspices of the Cancer Researchers in Nanotechnology (CRIN) R25T, followed by residency and fellowship at UC San Diego.
Dr. Vezeridis is highly committed to training the next generation, including students, residents, fellows, and engineering graduate students through co-directing Bio301B.
Dr. Vezeridis has a strong interest in medical device development and commercialization, and completed the Stanford Biodesign Faculty Fellowship. -
Anne Villeneuve
Berthold and Belle N. Guggenhime Professor and Professor of Developmental Biology and of Genetics
Current Research and Scholarly InterestsMechanisms underlying homologous chromosome pairing, DNA recombination and chromosome remodeling during meiosis, using the nematode Caenorhabditis elegans as an experimental system. High-resolution 3-D imaging of dynamic reorganization of chromosome architecture. Role of protease inhibitors in regulating sperm activation.
-
David Vu
Clinical Associate Professor, Pediatrics - Infectious Diseases
BioDr. Vu is a pediatric infectious diseases specialist who is researching human responses to dengue virus and malaria infections. He performed his undergraduate studies at the University of California, San Diego, and obtained his medical doctorate at the University of Pennsylvania School of Medicine. He trained in general pediatrics at UCSF Benioff Children's Hospital Oakland, and in pediatric infectious diseases at Emory University School of Medicine. His present studies on pediatric dengue and malaria co-infection are supported by an NIAID Career Development Award (K23 AI127909) and a Instructor K Award Support Program Award from the Maternal & Child Health Research Institute and Department of Pediatrics.
-
Soichi Wakatsuki
Professor of Photon Science and of Structural Biology
Current Research and Scholarly InterestsUbiquitin signaling: structure, function, and therapeutics
Ubiquitin is a small protein modifier that is ubiquitously produced in the cells and takes part in the regulation of a wide range of cellular activities such as gene transcription and protein turnover. The key to the diversity of the ubiquitin roles in cells is that it is capable of interacting with other cellular proteins either as a single molecule or as different types of chains. Ubiquitin chains are produced through polymerization of ubiquitin molecules via any of their seven internal lysine residues or the N-terminal methionine residue. Covalent interaction of ubiquitin with other proteins is known as ubiquitination which is carried out through an enzymatic cascade composed of the ubiquitin-activating (E1), ubiquitin-conjugating (E2), and ubiquitin ligase (E3) enzymes. The ubiquitin signals are decoded by the ubiquitin-binding domains (UBDs). These domains often specifically recognize and non-covalently bind to the different ubiquitin species, resulting in distinct signaling outcomes.
We apply a combination of the structural (including protein crystallography, small angle x-ray scattering, cryo-electron microscopy (Cryo-EM) etc.), biocomputational and biochemical techniques to study the ubiquitylation and deubiquitination processes, and recognition of the ubiquitin chains by the proteins harboring ubiquitin-binding domains. Current research interests including SARS-COV2 proteases and their interactions with polyubiquitin chains and ubiquitin pathways in host cell responses, with an ultimate goal of providing strategies for effective therapeutics with reduced levels of side effects.
Protein self-assembly processes and applications.
The Surface layers (S-layers) are crystalline protein coats surrounding microbial cells. S-layer proteins (SLPs) regulate their extracellular, self-assembly by crystallizing when exposed to an environmental trigger. We have demonstrated that the Caulobacter crescentus SLP readily crystallizes into sheets both in vivo and in vitro via a calcium-triggered multistep assembly pathway. Observing crystallization using a time course of Cryo-EM imaging has revealed a crystalline intermediate wherein N-terminal nucleation domains exhibit motional dynamics with respect to rigid lattice-forming crystallization domains. Rate enhancement of protein crystallization by a discrete nucleation domain may enable engineering of kinetically controllable self-assembling 2D macromolecular nanomaterials. In particular, this is inspiring designing robust novel platform for nano-scale protein scaffolds for structure-based drug design and nano-bioreactor design for the carbon-cycling enzyme pathway enzymes. Current research focuses on development of nano-scaffolds for high throughput in vitro assays and structure determination of small and flexible proteins and their interaction partners using Cryo-EM, and applying them to cancer and anti-viral therapeutics.
Multiscale imaging and technology developments.
Multimodal, multiscale imaging modalities will be developed and integrated to understand how molecular level events of key enzymes and protein network are connected to cellular and multi-cellular functions through intra-cellular organization and interactions of the key machineries in the cell. Larger scale organization of these proteins will be studied by solution X-ray scattering and Cryo-EM. Their spatio-temporal arrangements in the cell organelles, membranes, and cytosol will be further studied by X-ray fluorescence imaging and correlated with cryoEM and super-resolution optical microscopy. We apply these multiscale integrative imaging approaches to biomedical, and environmental and bioenergy research questions with Stanford, DOE national labs, and other domestic and international collaborators. -
Claire E Wakefield
Professor of Pediatrics (Quality of Life and Palliative Care)
BioI am a medical psychologist and researcher dedicated to improving quality of life for children affected by serious illness, as well as their families. My research spans pediatric palliative care, precision medicine, psycho-oncology, and global health, and is grounded in a deep commitment to compassionate, patient-centered care. I have published more than 340 journal articles and am named as Chief Investigator on competitive research grants totaling more than $55M.
I served as Continental President of SIOP Oceania and as a Director on the Board of the International Society of Pediatric Oncology (SIOP), advocating for children with cancer across 14 countries. I advise the World Health Organization on global childhood cancer initiatives and am a proud member of the Presidential Task Force on Advocacy for the Society of Pediatric Psychology. I am passionate about building national and global capacity in pediatric palliative care and ensuring that every child and family receives not only the best medical treatment, but also the emotional and psychological support they need. -
Rebecca D. Walker
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsInterests include international development in emergency care, healthcare disparities, wilderness medicine, human rights, administration
-
Dennis Wall
Professor of Pediatrics (Clinical Informatics), of Biomedical Data Science and, by courtesy, of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsSystems biology for design of clinical solutions that detect and treat disease
-
James Wall
Clinical Professor, Surgery - Pediatric Surgery
Current Research and Scholarly InterestsHealth Technology Innovation
-
Brian A. Wandell
Isaac and Madeline Stein Family Professor and Professor, by courtesy, of Electrical Engineering, of Ophthalmology and of Education
Current Research and Scholarly InterestsModels and measures of the human visual system. The brain pathways essential for reading development. Diffusion tensor imaging, functional magnetic resonance imaging and computational modeling of visual perception and brain processes. Image systems simulations of optics and sensors and image processing. Data and computation management for reproducible research.
-
C. Jason Wang, MD, PhD
LCY: Tan Lan Lee Professor and Professor of Pediatrics (General Pediatrics) and of Health Policy
BioDr. Wang is the Director of Center for Policy, Outcomes and Prevention. Prior to coming to Stanford in 2011, he was a faculty member at Boston University Schools of Medicine and Public Health. His other professional experiences include working as a management consultant with McKinsey and Company and serving as the project manager for Taiwan's National Health Insurance Reform Task-force. His current interests include: 1) pandemic preparedness; 2) role of generative Ai on child health and development; 3) use of mobile technology in improving quality of care; 4) assessing and improving the value of healthcare, and 5) healthcare delivery innovations and payment reforms.
-
Li Wang
Assistant Professor of Biology
Current Research and Scholarly InterestsWe study how the extraordinary diversity of cells and synapses in the brain is generated, organized, and maintained, and how these processes are disrupted in diseases such as neurodevelopmental disorders and brain cancer. By combining single-cell and spatial genomics, lineage tracing, perturbation screens, synaptic proteomics, and machine learning models, we aim to uncover the molecular rules that define neural identity and connectivity.
Our research spans two interrelated themes, each grounded in human biology and driven by cutting-edge technologies. By comparing these processes across species, we aim to uncover both conserved mechanisms and human-specific innovations that define the unique features of the human brain. -
Marie Wang
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsEvaluation and management of the febrile young infant and infections in hospitalized children; promotion of appropriate antibiotic use.
-
Nancy Ewen Wang
Professor of Emergency Medicine (Pediatrics), Emerita
Current Research and Scholarly Interests- Disparities in Emergency Medical Services for children.
- Efficacy of novel interventions for pediatric access to care.
- Teaching and supporting community-initiated interventions and programs internationally. -
Paul J. Wang, MD
John R. and Ai Giak L. Singleton Director, Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Bioengineering
Current Research and Scholarly InterestsDr. Wang's research centers on the development of innovative approaches to the treatment of arrhythmias, including more effective catheter ablation techniques, more reliable implantable devices, and less invasive treatments. Dr. Wang's clinical research interests include atrial fibrillation, ventricular tachycardia, syncope, and hypertrophic cardiomyopathy. Dr. Wang is committed to addressing disparities in care and is actively involved in increasing diversity in clinical trials.
-
Samantha Wang
Clinical Associate Professor, Medicine
BioDr. Samantha Wang is a Clinical Associate Professor in the Division of Hospital Medicine at Stanford University School of Medicine. She received her medical and masters in health sciences degrees from Yale School of Medicine and completed her Internal Medicine residency at Stanford, where she served as Chief Resident. She practices as a hospitalist at Stanford Health Care and works closely with residents and students in clinical teaching and mentorship. Her clinical focus is in patient-centered communication, and she directs inpatient implementation of the Serious Illness Care Program while studying strategies to improve the quality and impact of serious illness conversations for hospitalized patients.
Dr. Wang’s academic work spans health equity, medical education, and faculty development. She leads national collaborations advancing scholarship and advocacy in health equity and has received innovation grants to develop curricula addressing bias, structural racism, and diagnostic equity in clinical care. Her “5-Minute Moment for Racial Justice” curriculum has been disseminated nationally and internationally through Stanford CME and YouTube and translated into multiple languages. She received the American Board of Internal Medicine Professionalism Article Prize (2025) for her scholarship on professionalism and advancing health equity.
Dr. Wang leads faculty development initiatives within the Division of Hospital Medicine that support mentorship, scholarship, and community building. Her work focuses on creating environments where faculty can thrive academically while fostering inclusive learning communities for the next generation of physicians. In recognition of these efforts, she received the Stanford University Women’s Forum Inspiring Early Academic Career Award. -
Shan X. Wang
Leland T. Edwards Professor in the School of Engineering and Professor of Electrical Engineering and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsShan Wang was named the Leland T. Edwards Professor in the School of Engineering in 2018. He directs the Center for Magnetic Nanotechnology and is a leading expert in Edge AI, biosensors, information storage and spintronics. His research and inventions span across a variety of areas including Edge AI, magnetic biochips, in vitro diagnostics, cancer biomarkers, magnetic nanoparticles, magnetic sensors, magnetoresistive random access memory, and magnetic integrated inductors.
-
Sui Wang, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Taia T. Wang, MD, PhD, MSCI
Associate Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsLaboratory of Mechanisms in Human Immunity and Disease Pathogenesis
-
Xinnan Wang
Professor of Neurosurgery
Current Research and Scholarly InterestsMechanisms underlying mitochondrial dynamics and function, and their implications in neurological disorders.
-
Victoria Ward
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, digital health, preterm birth, human trafficking
-
Katja Gabriele Weinacht, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation and Regenerative Medicine)
Current Research and Scholarly InterestsPediatric Hematopoietic Stem Cell Transplantation
DiGeorge Syndrome
Genetic Immune Diseases
Immune Dysregulation -
Dana Weintraub
Clinical Associate Professor, Pediatrics - General Pediatrics
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
Irving Weissman
Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology
Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.
-
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Matthew T. Wheeler
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsTranslational research in rare and undiagnosed diseases. Basic and clinical research in cardiomyopathy genetics, mechanisms, screening, and treatment. Investigating novel agents for treatment of hypertrophic cardiomyopathy and new mechanisms in heart failure. Cardiovascular screening and genetics in competitive athletes, disease gene discovery in cardiomyopathy and rare disease. Informatics approaches to rare disease and multiomics. Molecular transducers of physical activity bioinformatics.
-
Michelle Williams, ScD
Professor of Epidemiology and Population Health
BioMichelle A. Williams, ScD, is Professor of Epidemiology and Population Health and Associate Chair for Academic Affairs in the Department of Epidemiology and Population Health at Stanford University, School of Medicine.
Dr. Williams' research focuses primarily on reproductive and perinatal epidemiology. Over three decades, she has integrated epidemiological, biological, and molecular approaches into rigorously designed research that has advanced understanding of placental abruption, gestational diabetes, and preeclampsia. Her research methodology includes: (1) identifying literature gaps; (2) developing robust epidemiological data systems across North America, Sub-Saharan Africa, Asia, and South America; and (3) integrating biochemical and molecular biomarkers into these platforms. She has effectively utilized various epidemiology study designs to investigate adverse reproductive and perinatal outcomes. Her consistent goal has been using biological and molecular biomarkers as objective measures of exposures and validated pre-clinical determinants of outcomes with clinical and global health significance. In 2019, in partnership with Apple Inc. and the National Institute of Environmental Health Sciences, she co-designed and currently co-leads the Apple Women's Health Study, a large-scale digital national study examining determinants of women's gynecological health.
Dr. Williams has advanced knowledge of understudied gynecological, obstetric, and perinatal outcomes while identifying novel risk factors. Her research has been funded by multiple NIH R01s, R03s, an SBIR, and HRSA grants, and she has served as co-investigator on numerous other grants. She has published over 540 peer-reviewed scientific articles and was elected to the National Academy of Medicine in 2016. In 2020, she received the Ellis Island Medal of Honor and was recognized by PR Week as one of the top 50 health influencers of the year.
Dr. Williams has been recognized for her excellence in teaching, as the recipient of the 2015 Harvard Chan School’s Outstanding Mentor Award, the UW’s Brotman Award for excellence in teaching (2007), the American Public Health Association’s Abraham Lilienfeld Award for education in epidemiology (2007), and the White House’s Presidential Award for Excellence in Science, Mathematics, and Engineering Mentoring (2012).
Before joining Stanford, Dr. Williams served as Dean of the Faculty at the Harvard T.H. Chan School of Public Health. Prior to her deanship, she was Professor and Chair of the Department of Epidemiology at Harvard Chan School and Program Leader of Population Health and Health Disparities Research Programs at Harvard's Clinical and Translational Sciences Center.
Dr. Williams previously had a distinguished career at the University of Washington School of Public Health. She holds an undergraduate degree in biology and genetics from Princeton University, a master's in civil engineering from Tufts University, and master's and doctoral degrees in epidemiology from the Harvard Chan School. -
Nolan Williams
Professor of Psychiatry and Behavioral Sciences (Major Laboratories & Clinical Translational Neurosciences Incubator)
BioNolan Williams, M.D. is a Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab. The long-term goals of his research program are to develop innovative technologies and therapeutics capable of modulating the neural circuitry disrupted in mood disorders, OCD, and other neuropsychiatric conditions. His team has been developing neuroimaging-based approaches to precisely target therapeutic delivery and predict treatment responses to therapeutic neuromodulation and psychedelics. Dr. Williams earned his M.D. and completed his dual residencies in neurology and psychiatry at the Medical University of South Carolina (MUSC). Triple board-certified in general neurology, general psychiatry, as well as behavioral neurology and neuropsychiatry, Dr. Williams brings a comprehensive background in clinical neuroscience to his role as a clinically active neuropsychiatrist. His expertise extends to the development and implementation of novel therapeutics, including devices and novel compounds, for central nervous system illnesses.
Over the past decade, Dr. Williams’ laboratory alongside collaborators at Stanford University have pioneered multiple novel therapeutic and human neuroscience approaches. Notably, Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) is the world's first non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression. SAINT received FDA Breakthrough Device Designation Status (2021) and FDA Clearance (2022) and is the first psychiatric treatment to be covered by Medicare New Technology Add-On Payment (NTAP). As of April 2024, SAINT has been reimbursed for patients suffering from severe depression within inpatient psychiatric units. The SAINT technology is being deployed both clinically and in research protocols in laboratories and hospitals worldwide. Dr. Williams also has an expertise in psychedelic medicines for neuropsychiatric illness and is the first investigator to conduct mechanistic clinical trials exploring the neurobiological effects of ibogaine.
His research accomplishments have garnered international recognition, earning prestigious awards from the Pritzker Neuropsychiatric Disorders Consortium, One Mind Institute, Wellcome Leap Foundation, International Brain Stimulation Conference, National Institute of Mental Health (Biobehavioral Research Award for Innovative New Scientists), Society of Biological Psychiatry (A. E. Bennett Award), along with multiple awards from the Brain Behavior Research Foundation (most notably the Gerald L. Klerman Award and Colvin Prize). His work has been featured in Scientific American, The New York Times, The Washington Post, USA Today, CBS Sunday Morning, and the TODAY Show. -
Darrell Wilson
Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.
-
Helen Wilson
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Wilson is a licensed clinical psychologist with expertise in the areas of trauma and life stress, women's wellness and sexual dysfunction, and lifestyle psychiatry. She provides clinical services in these areas and is Co-Director of the Lifestyle Psychiatry Clinic focused on holistic interventions incorporating physical activity, nutrition, stress management, sleep, social connection, and avoidance of risk substances. She has is also a 500 hour certified yoga instructor as has developed a group therapy program that integrates principles of yoga to support management of mood and anxiety symptoms. Dr. Wilson has completed federally funded research focused on relationships between childhood trauma and health risk behavior in adolescence and adulthood and is currently engaged in clinical research. Dr. Wilson has authored or co-authored over thirty journal articles and book chapters related to these topics, and she regularly presents her work at local and national conferences. She is lead editor of the 2023 book Facing Campus Sexual Assault and Relationship Violence With Courage: A Guide for Institutions and Clinicians on Prevention, Support, and Healing. She is currently engaged in a collaboration with Stanford Recreation and Wellness to evaluate the benefits of physical wellness and outdoor education courses.
-
Jeffrey J. Wine
Benjamin Scott Crocker Professor of Human Biology, Emeritus
Current Research and Scholarly InterestsThe goal is to understand how a defective ion channel leads to the human genetic disease cystic fibrosis. Studies of ion channels and ion transport involved in gland fluid transport. Methods include SSCP mutation detection and DNA sequencing, protein analysis, patch-clamp recording, ion-selective microelectrodes, electrophysiological analyses of transmembrane ion flows, isotopic metho
-
Virginia D. Winn, MD, PhD
Professor of Obstetrics and Gynecology (Reproductive, Perinatal & Stem Cell Biology Research)
Current Research and Scholarly InterestsThe Winn Laboratory seeks to understand the unique biological mechanisms of human placentation. While the placenta itself is one of the key characteristics for defining mammals, the human placenta is different from most available animal models: it is one of the most invasive placentas, and results in the formation of an organ comprised of cells from both the fetus and the mother. In addition to this fascinating chimerism, fetal cells are deeply involved in the remodeling of the maternal vasculature in order to redirect large volumes of maternal blood to the placenta to support the developing fetus. As such, the investigation of this human organ covers a large array of biological processes, and deals not only with understanding its endocrine function, but the physiologic process of immune tolerance, vascular remodeling, and cellular invasion.
-
Terry Winograd
Professor of Computer Science, Emeritus
BioProfessor Winograd's focus is on human-computer interaction design and the design of technologies for development. He directs the teaching programs and HCI research in the Stanford Human-Computer Interaction Group, which recently celebrated it's 20th anniversary. He is also a founding faculty member of the Hasso Plattner Institute of Design at Stanford (the "d.school") and on the faculty of the Center on Democracy, Development, and the Rule of Law (CDDRL)
Winograd was a founding member and past president of Computer Professionals for Social Responsibility. He is on a number of journal editorial boards, including Human Computer Interaction, ACM Transactions on Computer Human Interaction, and Informatica. He has advised a number of companies started by his students, including Google. In 2011 he received the ACM SIGCHI Lifetime Research Award. -
John Witte
Professor of Epidemiology and Population Health, of Biomedical Data Science and of Genetics
Current Research and Scholarly InterestsThe Witte Lab is a computational and statistical genetics group focused on deciphering the genetic and molecular mechanisms underlying cancer and other complex traits. We undertake integrative analyses across large multi-ancestry cohorts and biobanks, developing and applying methods at the interface of epidemiology, statistical genetics, and machine learning.
-
Wing Hung Wong
Stephen R. Pierce Family Goldman Sachs Professor of Science and Human Health and Professor of Biomedical Data Science
Current Research and Scholarly InterestsCurrent interest centers on the application of statistics, computation and engineering approaches to biology and medicine. We are particularly interested in questions concerning gene regulation, genome interpretation and their applications to precision medicine.
-
Jennifer Woo, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor, Pediatrics - CardiologyBioDr. Woo is a board-certified, fellowship-trained cardiologist with the Adult Congenital Heart Program at Stanford Health Care. She is also a clinical assistant professor in the Divisions of Cardiovascular Medicine and Pediatric Cardiology at Stanford University School of Medicine.
She diagnoses and treats a range of cardiovascular diseases, with a focus on adult congenital heart disease. Dr. Woo has Level III training with the National Board of Echocardiography, a certification that recognizes her experience in complex cardiac imaging. She also has specialized expertise in cardiac MRI. Each of her patients receives a personalized, comprehensive care plan delivered with compassion.
Dr. Woo is heavily involved in adult congenital heart disease research. She has a particular interest in imaging and heart failure in adults with congenital heart disease. She has received grant funding for her work, including from the Adult Congenital Heart Association. The National Institutes of Health awarded granted her the Ruth L. Kirschstein National Research Service Award.
She has published research in several peer-reviewed journals, such as the Journal of the American College of Cardiology and Pediatric Cardiology. Dr. Woo has presented her findings at regional and national meetings, including the Adult Congenital Heart Disease Bay Area Conference and the International Symposium on Adult Congenital Heart Disease.
Dr. Woo is a member of the Adult Congenital Heart Association, American College of Cardiology, American Heart Association, and American Society of Echocardiography. -
Jennifer Woo Baidal
Associate Professor of Pediatrics (Gastroenterology) and, by courtesy, of Epidemiology and Population Health
BioJennifer Woo Baidal is Associate Professor of Pediatrics, with tenure, and Associate Chair for Clinical Research in the Department of Pediatrics at Stanford University School of Medicine. She is also Chair for the North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Research Committee and a member of the American Academy of Pediatrics (AAP) Committee on Nutrition.
As the Principal Investigator for the Childhood Research in Obesity Prevention (CROP) lab, she has experience successfully obtaining funding through National Institutes of Health, PCORI, Robert Wood Johnson Foundation, and Doris Duke Foundation to lead action-oriented child health research. Dr. Woo Baidal’s health services research program aims to improve health for all children, with a focus on reducing childhood obesity. Her research program translates clinical, community, and epidemiologic findings into population-level interventions during pregnancy, infancy, and early childhood to reduce food insecurity, improve nutrition, and prevent childhood obesity and related chronic diseases. She has shown the vital role of early life factors on chronic disease prevention, including the promise of 'food as prevention' for infants in households with food insecurity. Her work has been featured by the New York Times, NPR, and CNN, and cited in AAP guidelines and by the National Academies of Science and Medicine. In 2023, she was honored with the AAP's Mitchell B Cohen Early to Mid-Career Leadership Award. -
Hsi-Yang Wu
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsI am interested in how the brain matures to control the bladder and external sphincter to achieve urinary continence. Using functional MRI of the brain, we are investigating if certain patterns of activity will predict which children will respond to therapy for incontinence.
-
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.
-
Joy Wu
Gerald M. Reaven, MD Professor of Endocrinology
Current Research and Scholarly InterestsMy laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic and cancer niches in the bone marrow microenvironment.
-
Sean M. Wu
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.
-
Courtney Wusthoff, MD
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsMy projects focus on clinical research in newborns with, or at risk, for brain injury. I use EEG in at-risk neonates to better understand the underlying pathophysiology of risk factors that may lead to worse outcomes. I am particularly interested in neonatal seizures and how they may exacerbate perinatal brain injury with a goal to identify treatments that might protect the vulnerable brain. I am also interested in EEG in other pediatric populations, as well as medical ethics and global health.
-
Tony Wyss-Coray, PhD
D. H. Chen Professor II
Current Research and Scholarly InterestsUse of genetic and molecular tools to dissect immune and inflammatory pathways in Alzheimer's and neurodegeneration.
-
Sheng Xu
Professor of Anesthesiology, Perioperative & Pain Medicine (Department Research) and, by courtesy, of Electrical Engineering
BioDr. Sheng Xu is a tenured professor and the inaugural Director of Emerging Technologies in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University, with a courtesy appointment in Electrical Engineering. He earned his B.S. degree in Chemistry from Peking University and his Ph.D. in Materials Science and Engineering from the Georgia Institute of Technology. Subsequently, he pursued postdoctoral studies at the Materials Research Laboratory at the University of Illinois at Urbana-Champaign. He then spent 10 years on the faculty at UC San Diego before joining Stanford in 2025. His research group is interested in developing new materials and fabrication methods for soft electronics. His research has been presented to the United States Congress as a testimony to the importance and impact of NIH funding.
-
Fan Yang
Associate Professor of Orthopaedic Surgery and of Bioengineering
Current Research and Scholarly InterestsOur lab’s mission is to develop therapies for regenerating human tissues lost due to diseases or aging, and to build tissue engineered 3D models for understanding disease progression and informing drug discovery. We invent biomaterials and engineering tools to elucidate and modulate biology, and also use biology to inform materials and engineering design. Our work is highly interdisciplinary, and is driven by unmet clinical needs or key gaps in biology.
-
Samuel Yang, MD, FACEP
Professor of Emergency Medicine (Adult Clinical/Academic)
Current Research and Scholarly InterestsDr. Yang's research is focused on bridging the translational gap at the interface of molecular biology, biochemistry, genome science, engineering, and acute care medicine. The investigative interest of the Yang lab falls within the general theme of developing integrative systems-level approaches for precision diagnostics, as well as data driven knowledge discoveries, to improve the health outcome and our understanding of complex critical illnesses. Using acute infectious disease models with complex host-pathogen dynamics, the goals of the Yang lab are divided into 3 areas:
1) Developing high-content, near-patient, diagnostic systems for rapid, unbiased pathogen detection and characterization to personalize treatment options and duration.
2) Integrating multi-omics molecular and phenotypic data layers with novel computational approaches into advanced diagnostics and predictive analytics for acute infections.
3) Understanding the biological roles of the noncanonical structures of extracellular nucleic acids in the contexts of neutrophil extracellular traps and biofilms. -
Yanmin Yang
Associate Professor of Neurology and Neurological Sciences (Neurology Research Faculty)
Current Research and Scholarly InterestsElucidate biological functions of cytoskeletal associated proteins in neurons. Define the cellular and molecular mechanisms underlying neurodegeneration in null mice.
-
Yunzhi Peter Yang
Professor of Orthopaedic Surgery and, by courtesy, of Materials Science and Engineering and of Bioengineering
On Partial Leave from 12/01/2025 To 05/31/2026Current Research and Scholarly InterestsThe Yang Lab focuses on next-generation solutions at the intersection of 3D printing, regenerative medicine, modular tissue engineering, biomaterials, and medical device innovation. Our research focuses on engineering dynamic, biomimetic microenvironments that promote cell growth, tissue regeneration, and functional restoration. We develop transformative technologies to treat a broad spectrum of musculoskeletal conditions—including multi-tissue healing challenges and complex traumatic injuries.
-
Jason Yeatman
Associate Professor of Pediatrics (Developmental-Behavioral Pediatrics), of Education and of Psychology
BioDr. Jason Yeatman is an Associate Professor in the Graduate School of Education and Department of Psychology at Stanford University and the Division of Developmental and Behavioral Pediatrics at Stanford University School of Medicine. Dr. Yeatman completed his PhD in Psychology at Stanford where he studied the neurobiology of literacy and developed new brain imaging methods for studying the relationship between brain plasticity and learning. After finishing his PhD, he took a faculty position at the University of Washington’s Institute for Learning and Brain Sciences before returning to Stanford.
As the director of the Brain Development and Education Lab, the overarching goal of his research is to understand the mechanisms that underlie the process of learning to read, how these mechanisms differ in children with dyslexia, and to design literacy intervention programs that are effective across the wide spectrum of learning differences. His lab employs a collection of structural and functional neuroimaging measurements to study how a child’s experience with reading instruction shapes the development of brain circuits that are specialized for this unique cognitive function. -
Ann Ming Yeh, MD
Clinical Professor, Pediatrics - Gastroenterology
BioDr. Ann Ming Yeh is a Clinical Professor at Stanford University in Pediatric Gastroenterology and practices at Stanford Medicine Children’s Health. She completed her residency and peds GI fellowship at Stanford University.
She completed a two-year distance learning fellowship through the Andrew Weil Center for Integrative Medicine where she gained additional expertise in mind-body therapies, botanicals, and nutritional supplements. She is also a formally trained and board-certified medical acupuncturist. She is currently the program director for the in person clinical fellowship for Pediatric Integrative Medicine at Stanford. With skill and compassion, Dr. Yeh treats her patients with a comprehensive, evidence-based, holistic approach.
Dr. Yeh’s research interests include diet therapies for inflammatory bowel disease, nutrition, integrative medicine for pediatric gastroenterology and medical education for pediatric integrative medicine. She is also the author of the book: Constipation Conquered: A Holistic Guide to Treating Your Child's Constipation.
Outside of medicine, she enjoys yoga, gardening, hiking, and traveling with her family. -
Ellen Yeh
Associate Professor of Pathology and of Microbiology and Immunology
Current Research and Scholarly InterestsOur research program focuses on understudied microbial ecology as solutions for planet health. We select organisms with important functional traits to understand their evolution, role in the environment, and potential for bioengineering toward sustainability solutions. We are currently working on nitrogen-fixing cyanobacteria and algae, genetic screens in diatoms, and algal biofuels.
-
Bo Yu, MD
Associate Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility)
Current Research and Scholarly InterestsDr. Yu’s lab is interested in ovarian physiology and pathology, as well as assisted reproductive technologies (ART).
-
James L. Zehnder, M.D.
Professor of Pathology (Research) and of Medicine (Hematology)
Current Research and Scholarly InterestsMy main research and clinical interests include molecular pathogenesis of acquired cytopenias, genetic testing for inherited non-malignant hematologic disorders, next-generation sequencing approaches to T and B cell clonality testing, somatic mutations in cancer and assessment of minimal residual disease in cancer patients.
-
Jamie Zeitzer
Professor (Research) of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsDr. Zeitzer is a circadian physiologist specializing in the understanding of the impact of light on circadian rhythms and other aspects of non-image forming light perception.
He examines the manner in which humans respond to light and ways to manipulate this responsiveness, with direct application to jet lag, shift work, and altered sleep timing in teens. Dr. Zeitzer has also pioneered the use of actigraphy in the determination of epiphenomenal markers of psychiatric disorders. -
Bing Melody Zhang
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy main research interests lie in the following areas:
1) HLA testing for BMT/solid organ transplantation
2) NGS-based TCR/Ig clonality/MRD testing
3) HLA testing in cellular therapy and oncology
4) Genetic/genomic testing for malignant and non-malignant hematologic disorders
5) HLA-related disease association/drug hypersensitivity testing. -
Yu Zhang
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.
Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.
The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases. -
J. Bradley Zuchero
Associate Professor of Neurosurgery
Current Research and Scholarly InterestsWe are primarily focused on understanding myelinating glia (oligodendrocytes and Schwann cells). How is myelin formed, dynamically remodeled to support learning, and why does regeneration of myelin fail in disease? We are also interested in understanding novel roles of myelin in the nervous system, beyond its textbook role as an electrical insulator. We combine in vivo and primary culture models with the generation of new cell biology tools to answer these questions.
-
Evan Zucker
Associate Professor of Radiology (Pediatric Radiology)
BioDr. Zucker serves as Director of Cardiovascular Imaging for Stanford Children’s Health. He is a board-certified pediatric and cardiovascular radiologist with a special interest in CT and MRI for congenital heart disease.
-
Donna Zulman
Professor of Medicine (Primary Care and Population Health)
Current Research and Scholarly Interests- Health care delivery models for patients with complex medical, social and behavioral needs.
- Interventions that address social determinants of health
- Effective communication and relationship-building in the clinical context
- Patient-facing technology (e.g., video-based care, eHealth technology) to facilitate access to health care
